Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
See Latest ArticlesThe role of capillaroscopy in differentiation of primary and secondary Raynauds phenomenon in rheumatic diseases: A review of the literature and two case reports
Rheumatology International, 06/30/09
Lambova SN et al. – Study concludes that nailfold capillaroscopy is useful in differentiating between primary and secondary Raynaud’s phenomenon (RP), and also in differentiating between different forms of connective autoimmune diseases as well as for their early diagnosis.
Methods- A systemic review of the current knowledge about the role of capillaroscopy in differentiation of primary and secondary RP in rheumatic diseases
- Capillaroscopy is of crucial value for diagnosis and differentiation of primary and secondary RP
- Appearance of abnormal capillaroscopic pattern inherits high positive predictive value for the development of systemic rheumatic disease
- Most specific pattern is found in SSc, so called “scleroderma pattern”
- This is characterized by the presence of dilated capillaries, hemorrhages, avascular areas and neoangiogeneis
- Similar changes are found in pts with dermatomyositis, mixed connective tissue disease, undifferentiated connective tissue disease and are called “scleroderma-like pattern”
- Absence of abnormal capillaroscopic findings can be regarded as a diagnostic criterion for primary RP
- Inclusion of pathologic capillaroscopic pattern may increase the sensitivity of ACR classification criteria for SSc.
Today in Autoimmune/Heritable...keeping you current
Receive free subspecialty "5-minute updates" via email
Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study
The Lancet Neurology, 10/15/09
A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis
Rheumatology, 10/23/09
Clinical and histologic evidence of salivary gland restoration supports the efficacy of rituximab treatment in Sjögrens syndrome
Arthritis & Rheumatism, 11/06/09
Today in Connective Tissue Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis
Rheumatology, 10/23/09
Treatment of adult inflammatory myositis with rituximab: An emerging therapy for refractory patients
Journal of Clinical Rheumatology (JCR), 10/08/09
Is pulmonary arterial hypertension really a late complication of systemic sclerosis
Chest, 10/12/09
Sponsor
Article Search
Sponsor